Serrano-Villar S, Martin-Pedraza L, Tiraboschi J, Novella M, et al. Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults with HIV (INSTINCT/GESIDA10918 Study). Clin Infect Dis 2025 Oct 10:ciaf565. doi: 10.1093.
PMID: 41070447